Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT01224366 · COMPLETED
Trial details
- NCT number
- NCT01224366
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-10-01
- Enrollment
- 448
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.